Skip to main content
Caplight Logo









Synoligo Biotechnologies

Synoligo Biotechnologies

Private
Morrisville, North CarolinaHealthcare & Life Scienceshttps://synoligo.com/

Last Round

Seed

Aug 1, 2022

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Synoligo Biotechnologies is a contract research and development organization (CRDO) that specializes in the manufacturing of complex and highly modified oligonucleotides for academic, biotech, and pharmaceutical sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

oligonucleotide synthesiscustom DNA synthesiscustom RNA synthesisCRDOcontract research organizationin vitro screeningmodified oligonucleotidesoligo synthesisCMC consultingchemistry manufacturing and controlsdrug discovery serviceshigh-throughput screeningtherapeutic oligonucleotidesbiotech R&Doligo vendor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synoligo Biotechnologies Comparables

Compare Synoligo Biotechnologies with similar companies based on industry and business-model similarity.

Synoligo Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ADViRNA
83%
Bio-Synthesis, Inc.
80%
Microsynth AG
73%

Synoligo Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 1, 2022

Key People

Founding team and executive leadership

Baozhong Zhao

CTO and Co-Founder

Founding Team

Xibo Li

CEO, Founder

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 187% MoM, reaching 8.4K.

  • Aug 19, 2026

    Grew 19% QoQ, from 36 to 43 employees.

Synoligo Biotechnologies Filings

Explore SEC and related filing metadata, where available.

Synoligo Biotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Synoligo Biotechnologies's valuation, stock price, and market status.

Is Synoligo Biotechnologies a public or private company?

Synoligo Biotechnologies is a private company.

What is the current stock price of Synoligo Biotechnologies?

Synoligo Biotechnologies is a private company with no public stock price. No recent secondary market data is available.

How much is Synoligo Biotechnologies worth (valuation)?

Valuation information for Synoligo Biotechnologies is not publicly available.

Can I buy Synoligo Biotechnologies stock?

Synoligo Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Synoligo Biotechnologies's last funding round?

Synoligo Biotechnologies's most recent funding round was Seed on August 1, 2022.

Who are the main investors in Synoligo Biotechnologies?

Investor information for Synoligo Biotechnologies is not publicly disclosed.

Will Synoligo Biotechnologies IPO soon?

No public IPO plans have been announced for Synoligo Biotechnologies.

How can I track Synoligo Biotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synoligo Biotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMorrisville, North Carolina
Employee Range35
Year FoundedN/A
Last FundingAug 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?